SPOTLIGHT -
ARMS-I COVID Study to Enroll Clinicians on the Frontlines
Robert Salata, MD, discusses the ARMS-I clinical trial that will enroll clinical staff caring for patients with COVID-19.
Read More
Public Health Perspective: COVID-19 Lessons and Challenges
Wendy M. Bamberg, MD, the editor of Contagion®’s Emerging and Re-emerging Infections section, shares her thoughts on social distancing, managing suspect cases, and lessons we can learn about COVID-19.
Contagion Live News Network: Coronavirus Updates for April 7, 2020
Stay up to date on the latest coronavirus updates from Tuesday April 7th.
CDC Launches COVIDView Report
The CDC will produce a weekly report called COVIDView. The report will be updated each Friday with US-based surveillance information.
Contagion Live News Network: Coronavirus Updates for April 6, 2020
Catch up on the latest coronavirus news from April 6, 2020.
Contagion Live News Network: Coronavirus Updates for April 3, 2020
Check out the latest coronavirus news from April 3, 2020.
Contagion Live News Network: Coronavirus Updates for April 2, 2020
Check out the latest coronavirus news from April 2, 2020.
FDA Launches Coronavirus Treatment Acceleration Program
The goal of the program will be to quickly bring effective medical countermeasures to patients while also supporting research to assess the safety and efficacy of these therapies.
FDA Provides Update on COVID-19 Diagnostic Review
As of March 30th, 20 emergency use authorizations have been granted for COVID-19 diagnostics.
Evaluating Therapies for COVID-19 and Staying Engaged During a Pandemic
Erin K. McCreary, PharmD, BCPS, BCIDP, discusses emerging literature on potential therapies COVID-19 and how the infectious disease community can work together during this pandemic.
Contagion Live News Network: Coronavirus Updates for March 25, 2020
Stay on top of coronavirus news from March 24, 2020.
Contagion Live News Network: Coronavirus Updates for March 20, 2020
Stay on top of coronavirus developments from March 20, 2020.
FDA Provides Update on Development of COVID-19 Countermeasures
The agency notes that they are working closely with industry officials to expedite efforts to develop countermeasures for COVID-19.
Contagion Live News Network: Coronavirus Updates for March 19, 2020
Stay on top of coronavirus developments from March 19, 2020.
Abbott Receives FDA Emergency Use Authorization for COVID-19 Test
According to Abbott, the systems can run high volumes of up to 470 tests in 24 hours.
Contagion Live News Network: Coronavirus Updates for March 18, 2020
Stay on top of coronavirus developments from March 18, 2020.
NIH Launches Phase 1 Clinical Trial for COVID-19 Vaccine
The trial will enroll 45 health adult participants between the ages of 18 to 55 years of age over a 6-week period. The first trial participant received the investigation vaccine, mRNA-1273, today.
Sarilumab Will Be Evaluated for Patients With Severe COVID-19
Sanofi and Regeneron are launching a clinical trial program which will evaluate sarilumab (Kevzara) in patients who are hospitalized with severe coronavirus (COVID-19) infection.
COVID-19: New Jersey Institutes Statewide Curfew
New Jersey residents are being instructed to remain in their homes between the hours of 8pm and 5am in attempt to control the spread of COVID-19 in the Garden State.
Contagion Live News Network: Coronavirus Updates for March 13, 2020
Stay on top of coronavirus developments from March 13, 2020.
Onyema Ogbuagu, MD: DISCOVER Week 96 Results
Contagion® spoke to Onyema Ogbuagu, MD, who presented the week 96 results from the DISCOVER study evaluating F/TAF and F/TDF.
DISCOVER 96 Week Results Back F/TAF Efficacy
There was a statistically significant difference in renal safety which favored F/TAF over F/TDF at Week 96.
The London Patient Remains in HIV Remission After 30 Months
The abstract authors report that both HIV viral load in plasma and proviral HIV DNA in CD4 cells have remained below levels of detection for up to 30 months.
Steffanie Strathdee, PhD: Preventing HIV Among People Who Inject Drugs
“There are structural drivers that are impeding prevention and treatment among people who inject drugs,” Strathdee said in an interview with Contagion®.
Cabotegravir and Rilpivirine Maintains Efficacy in FLAIR 96-Week Data
New Week 96 data from the FLAIR study indicate that once-monthly injections of cabotegravir and rilpivirine remains non-inferior and safe when compared with the daily, oral 3-drug regimen of ABC/DTG/3TC.
Prenatal Care, Universal Syphilis Screening Critical for US Women
A team of investigators hypothesized that prevalent syphilis infection in women with and without HIV may be a way to identify individuals who are at an elevated risk of a stillbirth over time.
Gaps Remain in Immediate ART Initiation in NYC Clinics
Despite the high level of knowledge surrounding immediate initiation of ART, the practice is not yet the standard of care across clinics in NYC.
GS-9722 Generally Safe, Well-Tolerated in Two Studies
Investigators conducted 2 studies on intravenously administered GS-9722, 1 in HIV-negative participants and 1 in virally suppressed people with HIV.
Contagion Live News Network: Coronavirus Updates for March 6, 2020
Stay on top of coronavirus developments from March 6, 2020.
US Flu Cases Reach 32 Million, Pediatric Hospitalization Rates Hit Record High
The influenza hospitalization rate for children and young adults has surpassed the rate documented during the second wave of the 2009 H1N1 pandemic.